Responses
Oral Presentations
Abstract Session PReS: Clinical and basic developments in paediatric rheumatology
OP0060 Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data from a Phase 3 Trial
Compose a Response to This Article
Other responses
No responses have been published for this article.